High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults (ACHIEVE)
|ClinicalTrials.gov Identifier: NCT03856879|
Recruitment Status : Recruiting
First Posted : February 27, 2019
Last Update Posted : September 23, 2019
|Condition or disease||Intervention/treatment||Phase|
|COPD HIV/AIDS||Behavioral: Proactive E-consult||Not Applicable|
Emerging data support that barriers to high quality COPD care are likely accentuated in HIV+ persons. Taken together, decreased recognition of smoking, lack of referral for pulmonary evaluation, worse symptoms and greater exacerbation rates point towards low quality of care for COPD in HIV+ patients. Our preliminary data supports that COPD is inadequately managed in HIV+ patients. These data demonstrate that current management of COPD in HIV+ patients do not adhere to guidelines, that ICS may be over-prescribed and long-acting bronchodilators under-utilized, and support the need to improve evidence-based COPD care in HIV+ patients. Appropriate use of COPD therapies is particularly important for HIV+ patients, as side effects and toxicities could be more harmful in HIV+ patients, given their concomitant multimorbidity and polypharmacy. In summary, an intervention to improve the evidence-based delivery of COPD care can improve outcomes for HIV+ patients. Benefits may extend beyond COPD-related measures. Appropriate use of COPD controller medications can decrease symptoms and exacerbations, and improve health-related quality of life. Our proposed study to has a high potential to substantially improve the quality of care for COPD and patient-centered outcomes for a large number of HIV+ Veterans.
This study tests an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV+ patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care, which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient. The investigators will leverage the Department of Veterans Affairs (VA) clinical and informatics infrastructures to communicate between intervention-team members developing the recommendations (using VA Extension for Community Health Outcomes [ECHO]) and to patients' clinical providers through the electronic health record (EHR) as an E-consult. To limit the burden on the provider, the intervention team will draft recommendations as preliminary orders for providers to review. To preserve their autonomy, the provider has the discretion to endorse (sign), modify or cancel the orders.
This study uses a two-arm cluster randomized controlled trial intervention design grounded in the chronic care model with outcomes evaluated using the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework. The investigators will evaluate barriers and facilitators of optimal COPD care for HIV+ patients, and of effective adoption, implementation and maintenance of the proactive E-consult program, guided by the Consolidated Framework for Implementation Research (CFIR).
This study involves the recruitment and enrollment of two populations: providers and patients. Providers will be recruited at the beginning of the study; providers that enroll will be randomly chosen to either provide usual care (control) or to receive E-consults for their HIV+ patients with COPD (intervention). Patients of enrolled providers will be recruited after attending an appointment with their provider. Enrolled patients will be asked to complete a set of surveys, and some patients will be offered the opportunity to participate in an interview about their care.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||504 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Providers will be randomly assigned to the intervention or control group, stratified by site, provider type and panel size.|
|Masking:||Single (Outcomes Assessor)|
|Masking Description:||Study staff conducting patient surveys and evaluating quality of COPD care will be blinded to intervention/control assignment of the patient's provider.|
|Primary Purpose:||Health Services Research|
|Official Title:||AdvanCing High-quality COPD Care for People With Immune Dysfunction by Implementing EVidence-based Management Through Proactive E-consults|
|Actual Study Start Date :||May 21, 2019|
|Estimated Primary Completion Date :||December 31, 2022|
|Estimated Study Completion Date :||May 31, 2023|
No Intervention: Usual care
Providers in this arm will provide usual care to their HIV+ patients with COPD.
Experimental: Proactive E-consult
Providers in this arm will receive proactive E-consults with expert recommendations for COPD care prior to appointments with HIV+ patients with COPD.
Behavioral: Proactive E-consult
E-consult recommendations and orders will be developed by a panel of pulmonologists and will address a range of care elements for patients with COPD.
- % of COPD care recommendations received by patients of enrolled providers [ Time Frame: 6 months following provider/patient appointment ]% of COPD care recommendations received by the patient, examined collectively for each patient and individually by type of recommendation (e.g. use of spirometry, long acting bronchodilator, smoking cessation, vaccination, etc.) to assess the overall quality of COPD care.
- Patient health-related quality of life [ Time Frame: 6 weeks following provider/patient appointment ]Patient-reported health-related quality of life on the Medical Outcomes 12-item short form (SF-12), a patient self-report survey. This survey is a 12-item scale with two subscales (mental and physical components). Summary scores range from 0-100, with higher scores reflecting better health.
- HIV provider satisfaction with specialty-care support [ Time Frame: Baseline: prior to intervention roll-out. Follow-up: after exposure to intervention (defined as having received at least 2 E-consults), up to 3 years. ]Baseline and follow-up self-report surveys (all participating providers) and interviews (sample of providers)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03856879
|Contact: Janaki M Torrence, MS||206-277-1548 ext 61548||Janaki.Torrence@va.gov|
|United States, California|
|VA Greater Los Angeles Healthcare System||Not yet recruiting|
|Los Angeles, California, United States, 90073|
|Contact: Guy Soo Hoo, MD|
|United States, Colorado|
|VA Eastern Colorado Health Care System||Recruiting|
|Denver, Colorado, United States, 80012|
|Contact: Kristine Erlandson, MD|
|United States, Connecticut|
|VA Connecticut Healthcare System||Not yet recruiting|
|New Haven, Connecticut, United States, 06111|
|Contact: Kathleen Akgun, MD|
|United States, District of Columbia|
|Washington DC VA Medical Center||Recruiting|
|Washington, District of Columbia, United States, 20422|
|Contact: Amy Weintrob, MD|
|United States, Georgia|
|Atlanta VA Health Care System||Not yet recruiting|
|Atlanta, Georgia, United States, 30033|
|Contact: Cherry Wongtrakool, MD|
|Principal Investigator:||David H. Au, MD, MS||VA Puget Sound Health Care System|
|Principal Investigator:||Kristina A. Crothers, MD||VA Puget Sound Health Care System|
|Principal Investigator:||Christian D. Helfrich, PhD, MPH||VA Puget Sound Health Care System|